LIVN Q1 2021 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$248M+2.1% YoY

Gross Profit

$163M66.0% margin

Operating Income

-$6M-2.3% margin

Net Income

-$31M-12.4% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

-8.1%

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$11M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.3B

Stockholders' Equity

$1.1B

Cash & Equivalents

$253M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$248M	$242M	+2.1%
Gross Profit	$163M	$171M	-4.2%
Operating Income	-$6M	$23M	-124.7%
Net Income	-$31M	$38M	-181.8%

Revenue Segments

Cardiovascular Segment

$143M58%

Neuromodulation Segment

$104M42%

Geographic Segments

UNITED STATES

$133M54%

Locations Excluding The United States And Europe

$63M26%

Europe

$51M21%